サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：シングルセルゲノミクス市場：技術別、製品別、ワークフロー別、ユーザー別、国別予測（2022年～2026年）
市場調査レポート
商品コード
1036268

シングルセルゲノミクス市場：技術別、製品別、ワークフロー別、ユーザー別、国別予測（2022年～2026年）

Single Cell Genomics Markets. Forecasts by Technology, Product, Workflow, User & Country. With Executive and Consultant Guides. Including Customized Forecasting and Analysis. 2022 to 2026
出版日: | 発行: Howe Sound Research | ページ情報: 英文 300 Pages | 納期: 即日から翌営業日
AI翻訳ツール 提供対象
ご購入後の翻訳ツール提供について

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=130.29円
シングルセルゲノミクス市場：技術別、製品別、ワークフロー別、ユーザー別、国別予測（2022年～2026年）
出版日: 2021年11月10日
発行: Howe Sound Research
ページ情報: 英文 300 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

シングルセルゲノミクスは、科学的な研究開発の柱として台頭しており、医療のあらゆる面で応用されています。特に免疫・腫瘍学や微生物学に関連した新しい臨床応用に足を踏み入れつつあります。しかし、最大の市場は依然として研究分野にあり、個々の細胞のゲノミクスを理解することで、バイオテクノロジーの全く新しい世界を切り開くことができるため、市場は活況を呈しています。

当レポートでは、シングルセルゲノミクスの世界市場について調査し、市場の概要とともに、技術別、製品別、ワークフロー別、ユーザー別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

  • 状況分析とCOVIDの更新
  • エグゼクティブおよびマーケティングスタッフのためのガイド
  • 投資アナリストおよび経営コンサルタントのためのガイド

第2章 イントロダクションと市場の定義

  • シングルセルゲノミクスとは何か
  • SCG-まだ初期の段階
  • 市場の定義
  • 調査手法
  • ゲノムのサイジング
  • 設置ベースのハイスループットシーケンス施設リスト

第3章 シングルセルゲノミクス-技術ガイド

  • 単一細胞の分離
    • FACS
    • LCM
    • マイクロマニピュレーター
    • マイクロフルイディクス
  • 増幅
    • WTA-全トランスクリプトーム増幅
    • WGA-全ゲノム増幅
  • PCR
  • NGS
  • マイクロアレイ
  • デジタル空間プロファイリング（DSP）技術

第4章 業界の概要

  • ダイナミックな市場のプレーヤー
    • 学術研究室
    • ゲノム計装サプライヤー
    • 細胞分離および表示機器サプライヤー
    • 細胞株および試薬サプライヤー
    • 製薬会社または試薬メーカー
    • 監査機関
    • 認証機関

第5章 市場動向

  • 成長促進要因
    • 免疫腫瘍学
    • 研究範囲
    • テクノロジーの成熟度と収束
    • コストの低下
  • 成長抑制要因
    • 競合
    • 機器の統合
    • テクノロジーシフト
    • テクノロジーの制限
  • 技術開発
    • 空間プロファイリング
    • 統合
    • ビッグデータ
    • キットと商品

第6章 シングルセルゲノミクスの最近の開発

第7章 主要なシングルセルゲノミクス企業のプロファイル

  • 10x Genomics
  • 1CellBio
  • Agilent
  • Beckman Coulter
  • Becton Dickinson
  • Bio-Rad
  • Bitbiome
  • Bruker
  • Cell Microsystems
  • Cellsee Diagnostics
  • CellSorter
  • Cytena
  • CytoTrack
  • Dolomite Bio
  • Fluidigm
  • Fluxion Biosciences
  • Illumina
  • IncellDx
  • Labcyte
  • Leica Microsystems
  • Miltenyi Biotec
  • Mission Bio
  • Oxford Nanopore Technologies
  • NanoString
  • Perkin Elmer
  • Qiagen
  • Readcoor
  • Roche Molecular Diagnostics
  • S2 Genomics
  • Silicon Biosystems
  • Singulomics
  • Sony
  • Takara Bio
  • Thermo Fisher
  • Watchmaker Genomics

第8章 シングルセルゲノミクスの世界市場規模

  • 世界市場概要、国別
  • 世界の市場規模、技術別
  • 世界市場-概要、製品別
  • 世界市場-概要、ワークフロー別
  • 世界市場-概要、エンドユーザー別

第9章 シングルセルゲノミクス市場、技術別

  • PCR
  • qPCR
  • NGS
  • マイクロアレイ
  • その他

第10章 シングルセルゲノミクス市場、製品別

  • 装置
  • 試薬
  • ソフトウェアおよびその他

第11章 シングルセルゲノミクス市場、ワークフロー別

  • 細胞分離
  • サンプル調製
  • ゲノム解析

第12章 シングルセルゲノミクス市場、エンドユーザー別

  • 研究
  • バイオ医薬品
  • 臨床
  • その他

第13章 付録

図表

Table of Tables

  • Table 1 Global List of Gene Sequencing Facilities
  • Table 2 Cell Isolation Overview
  • Table 3 Market Players by Type
  • Table 4 Five Factors Driving Growth
  • Table 5 Three Factors Limiting Growth
  • Table 6 Single Cell Genomics Global Market by Country/Region
  • Table 7 Single Cell Genomics Global Market by Technology
  • Table 8 Global Market by Product
  • Table 9 Global Market by Workflow
  • Table 10 Global Market by End User
  • Table 11 PCR Market by Country
  • Table 12 qPCR Market by Country
  • Table 13 NGS Market by Country
  • Table 14 Microarray Market by Country
  • Table 15 Other Technology Market by Country
  • Table 16 Instrument Market by Country
  • Table 17 Reagent Market by Country
  • Table 18 Software & Other Market by Country
  • Table 19 Cell Isolation Market by Country
  • Table 20 Sample Preparation Market by Country
  • Table 21 Genomic Analysis Market by Country
  • Table 22 Research Market by Country
  • Table 23 BioPharma Market by Country
  • Table 24 Clinical Market by Country
  • Table 25 Other End User Market by Country

Table of Figures

  • Figure 1 Selected Genetics Companies Growth
  • Figure 2 Size of Different Genomes
  • Figure 3 flourescence Activated Sorter
  • Figure 4 Market Size by Country
  • Figure 5 Global Market by Technology - Base vs. Final Year
  • Figure 6 Technology Market Base Year
  • Figure 7 Technology Market Final Year
  • Figure 8 Technology Share by Year
  • Figure 9 Technology Segment Growth
  • Figure 10 Product - Base vs. Final Year
  • Figure 11 Product Market Base Year
  • Figure 12 Product Market Final Year
  • Figure 13 Product Share by Year
  • Figure 14 Product Segment Growth
  • Figure 15 Workflow - Base vs. Final Year
  • Figure 16 Workflow Market Base Year
  • Figure 17 Workflow Market Final Year
  • Figure 18 Workflow Share by Year
  • Figure 19 Workflow Segment Growth
  • Figure 20 End User - Base vs. Final Year
  • Figure 21 End User Market Base Year
  • Figure 22 End User Market Final Year
  • Figure 23 End User Share by Year
  • Figure 24 End User Segment Growth
  • Figure 25 Chart - PCR Market Growth
  • Figure 26 Chart qPCR Market Growth
  • Figure 27 Chart - NGS Market Growth
  • Figure 28 Chart - Microarray Market Growth
  • Figure 29 Chart - Other Technology Market Growth
  • Figure 30 Chart - Instrument Market Growth
  • Figure 31 Chart - Reagent Market Growth
  • Figure 32 Chart - Software & Other Market Growth
  • Figure 33 Chart - Cell Isolation Market Growth
  • Figure 34 Chart - Sample Preparation Market Growth
  • Figure 35 Chart - Genomic Analysis Market Growth
  • Figure 36 Chart - Research Market Growth
  • Figure 37 Chart - BioPharma Market Growth
  • Figure 38 Chart - Clinical Market Growth
  • Figure 39 Chart - Other End User Market Growth
  • Figure 40 FDA Cancer Drug Approvals by Year
  • Figure 41 Clinical Trials for Immunotherapy by Year
  • Figure 42 Pie Chart of Prevalence of Cancer Treatments
目次

OVERVIEW:

Single Cell Genomics is emerging as a mainstay of scientific research and development. New life forms have already been identified. This means new diseases and new cures. There are applications in every aspect of healthcare. Just coming out of the lab it is finding its footing in new clinical applications especially related to immune-oncology and microbiology. But the largest market is still in research and the market is booming as understanding the genomics of individual cells opens up a whole new world of biotechnology. Get a firm handle on understanding the enormous potential of Single Cell Genomics with this comprehensive report.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Situation Analysis & COVID Update
    • 1.1.1 Selected Genetic Testing Companies Revenue & Growth
    • 1.1.2 Selected Genetic Testing Companies Revenue & Growth - Chart
  • 1.2 Guide for Executives and Marketing Staff
  • 1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

  • 2.1 What is Single Cell Genomics?
  • 2.2 SCG - Still Early Days
  • 2.3 Market Definition
    • 2.3.1 Market Size
    • 2.3.2 Currency
    • 2.3.3 Years
  • 2.4 Methodology
    • 2.4.1 Authors
    • 2.4.2 Sources
  • 2.5 Sizing the Genome - Not What You Think
    • 2.5.1 Cost, Price and Genome Size, Pricing Practice
  • 2.6 GLOBAL LISTING OF HIGH THROUGHPUT SEQUENCING ESTABLISHMENTS INSTALLED BASE - Location & Contacts

3 Single Cell Genomics - Guide to Technology

  • 3.1 Isolating Single Cells
    • 3.1.1 FACS
    • 3.1.2 LCM
    • 3.1.3 Micromanipulators
    • 3.1.4 Microfluidics
  • 3.2 Amplification
    • 3.2.1 WTA - Whole Transcriptome Amplification
    • 3.2.2 WGA - Whole Genome Amplification
  • 3.3 PCR
  • 3.4 NGS
  • 3.5 Microarray
  • 3.6 Digital Spatial Profiling (DSP) Technology

4 Industry Overview

  • 4.1 Players in a Dynamic Market
    • 4.1.1 Academic Research Lab
    • 4.1.2 Genomic Instrumentation Supplier
    • 4.1.3 Cell Separation and Viewing Instrumentation Supplier
    • 4.1.4 Cell Line and Reagent Supplier
    • 4.1.5 Pharmaceutical or Reagent Company
    • 4.1.6 Audit Body
    • 4.1.7 Certification Body

5 Market Trends

  • 5.1 Factors Driving Growth
    • 5.1.1 Immuno-oncology
    • 5.1.2 Research Range
    • 5.1.3 Technology Maturity & Convergence
    • 5.1.4 Declining Costs
  • 5.2 Factors Limiting Growth
    • 5.2.1 Competition
    • 5.2.2 Instrument Integration
    • 5.2.3 Technology Shift
    • 5.2.4 Technology Limitations
  • 5.3 Technology Development
    • 5.3.1 Spatial Profiling
    • 5.3.2 Integration
    • 5.3.3 Big Data
    • 5.3.4 Kits and Commodities

6 Single Cell Genomics Recent Developments

  • 6.1 Recent Developments - Importance and How to Use This Section
    • 6.1.1 Importance of These Developments
    • 6.1.2 How to Use This Section
  • 6.2 Pfizer Centralizes Single Cell Data on Seven Bridges System
  • 6.3 Consortium to Standardize Single-Cell Sequencing
  • 6.4 Scienion, Cellenion Enter Licensing Deal
  • 6.5 Immunai Acquires Swiss Bioinformatics Firm Nebion
  • 6.6 Startup MiCareo Targets Rare Cell Isolation Market
  • 6.7 Parse Biosciences Lowers Cost Barriers to Single-Cell Transcriptomics
  • 6.8 Deepcell Advancing Tech for Single-Cell Genomics
  • 6.9 10x Genomics Outlines 2021 Growth Plans
  • 6.10 Single-Cell Genomics Firm Analytical Biosciences Inks Deal with BioMap
  • 6.11 IsoPlexis Features Cheaper, More Flexible Single-Cell Proteomic Systems
  • 6.12 DNTR-Seq Combines WGS, Transcriptomics in Single Cells
  • 6.13 BitBiome Builds Single-Cell Bacterial Sequencing Business
  • 6.14 S2 Genomics Signs Distribution Agreements for Asia-Pacific
  • 6.15 Single-Cell COVID-19 Study Investigates Immune Hyperactivation
  • 6.16 Levitas Bio to Launch Magnetic Levitation Cell Separation Platform
  • 6.17 Single-Cell and Spatial Genomics
  • 6.18 Single-Cell Genomics
  • 6.19 Namocell, Takara Bio, HepaTx Partner on Single-Cell Genomics
  • 6.20 Vizgen Launches With $14M Series A Financing
  • 6.21 SeqWell Raises $9M in Series B Round
  • 6.22 MGI Tech Introduces Portable Sequencer, Single-Cell Prep Device
  • 6.23 Celsius Therapeutics to Use Single-Cell Platform in Immuno-Oncology
  • 6.24 10x Genomics Expects $271M In Proceeds
  • 6.25 Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance
  • 6.26 Bio-Rad, 10x Genomics Claim Single-Cell Patent Fight Victories on Different Fronts
  • 6.27 Bio-Rad Launches its Single Cell scATAC-Seq Solution
  • 6.28 10x Genomics Acquires Spatial Transcriptomics
  • 6.29 Takara Bio strengthens its IP position on single cell RNA-seq
  • 6.30 Mission Bio Launches Tapestri® for Targeted Single-Cell DNA Custom Panels
  • 6.31 Sony MA900 Cell Sorter Nominated
  • 6.32 UNC Cure Center and Cell Microsystems Receive NIH Contract for Single Cell HIV
  • Diagnostic Assay
  • 6.33 Bio-Rad's dd-PCR tests for leukemia cleared
  • 6.34 Cytena GmbH land EUR 3M in Series A

7 Profiles of Key Single Cell Genomics Companies

  • 7.1 10x Genomics
  • 7.2 1CellBio
  • 7.3 Agilent
  • 7.4 Beckman Coulter
  • 7.5 Becton Dickinson
  • 7.6 Bio-Rad
  • 7.7 Bitbiome
  • 7.8 Bruker
  • 7.9 Cell Microsystems
  • 7.10 Cellsee Diagnostics
  • 7.11 CellSorter
  • 7.12 Cytena
  • 7.13 CytoTrack
  • 7.14 Dolomite Bio
  • 7.15 Fluidigm
  • 7.16 Fluxion Biosciences
  • 7.17 Illumina
  • 7.18 IncellDx
  • 7.19 Labcyte
  • 7.20 Leica Microsystems
  • 7.21 Miltenyi Biotec
  • 7.22 Mission Bio
  • 7.23 Oxford Nanopore Technologies
  • 7.24 NanoString
  • 7.25 Perkin Elmer
  • 7.26 Qiagen
  • 7.27 Readcoor
  • 7.28 Roche Molecular Diagnostics
  • 7.29 S2 Genomics
  • 7.30 Silicon Biosystems
  • 7.31 Singulomics
  • 7.32 Sony
  • 7.33 Takara Bio
  • 7.34 Thermo Fisher
  • 7.35 Watchmaker Genomics

8 Single Cell Genomics Global Market Size

  • 8.1 Global Market Overview by Country
    • 8.1.1 Table - Global Market by Country
    • 8.1.2 Chart - Global Market by Country
  • 8.2 Global Market Size by Technology - Overview
    • 8.2.1 Table - Global Market by Technology
    • 8.2.2 Chart - Global Market by Technology - Base/Final Year Comparison
    • 8.2.3 Chart - Global Market by Technology - Base Year
    • 8.2.4 Chart - Global Market by Technology - Final Year
    • 8.2.5 Chart - Global Market by Technology - Share by Year
    • 8.2.6 Chart - Global Market by Technology - Segment Growth
  • 8.3 Global Market by Product - Overview
    • 8.3.1 Table - Global Market by Product
    • 8.3.2 Chart - Global Market by Product - Base/Final Year Comparison
    • 8.3.3 Chart - Global Market by Product - Base Year
    • 8.3.4 Chart - Global Market by Product - Final Year
    • 8.3.5 Chart - Global Market by Product - Share by Year
    • 8.3.6 Chart - Global Market by Product - Segment Growth
  • 8.4 Global Market by Workflow - Overview
    • 8.4.1 Table - Global Market by Workflow
    • 8.4.2 Chart - Global Market by Workflow - Base/Final Year Comparison
    • 8.4.3 Chart - Global Market by Workflow - Base Year
    • 8.4.4 Chart - Global Market by Workflow - Final Year
    • 8.4.5 Chart - Global Market by Workflow - Share by Year
    • 8.4.6 Chart - Global Market by Workflow - Segment Growth
  • 8.5 Global Market by End User - Overview
    • 8.5.1 Table - Global Market by End User
    • 8.5.2 Chart - Global Market by End User - Base/Final Year Comparison
    • 8.5.3 Chart - Global Market by End User - Base Year
    • 8.5.4 Chart - Global Market by End User - Final Year
    • 8.5.5 Chart - Global Market by End User - Share by Year
    • 8.5.6 Chart - Global Market by End User - Segment Growth

9 Global Market by Technology

  • 9.1 PCR Market
    • 9.1.1 Table - PCR Market by Country
    • 9.1.2 Chart - PCR Market by Country
  • 9.2 qPCR Market
    • 9.2.1 Table - qPCR Market by Country
    • 9.2.2 Chart - qPCR Market Growth
  • 9.3 NGS Market
    • 9.3.1 Table - NGS Market by Country
    • 9.3.2 Chart - NGS Market Growth
  • 9.4 Microarray Market
    • 9.4.1 Table - Microarray Market by Country
    • 9.4.2 Chart - Microarray Market Growth
  • 9.5 Other Technology Market
    • 9.5.1 Table - Other Technology Market by Country
    • 9.5.2 Chart - Other Technology Market Growth

10 Single Cell Genomics Market by Product

  • 10.1 Instrument Market
    • 10.1.1 Table - Instrument Market by Country
    • 10.1.2 Chart - Instrument Market Growth
  • 10.2 Reagent Market
    • 10.2.1 Table - Reagent Market by Country
    • 10.2.2 Chart - Reagent Market Growth
  • 10.3 Software & Other Market
    • 10.3.1 Table - Software & Other Market by Country
    • 10.3.2 Chart - Software & Other Market Growth

11 Single Cell Genomics Market by Workflow

  • 11.1 Cell Isolation Market
    • 11.1.1 Table - Cell Isolation Market by Country
    • 11.1.2 Chart - Cell Isolation Market Growth
  • 11.2 Sample Preparation Market
    • 11.2.1 Table - Sample Preparation Market by Country
    • 11.2.2 Chart - Sample Preparation Market Growth
  • 11.3 Genomic Analysis Market
    • 11.3.1 Table - Genomic Analysis Market by Country
    • 11.3.2 Chart - Genomic Analysis Market Growth

12 Single Cell Genomics Market by End User

  • 12.1 Research Market
    • 12.1.1 Table - Research Market by Country
    • 12.1.2 Chart - Research Market Growth
  • 12.2 BioPharma Market
    • 12.2.1 Table - BioPharma Market by Country
    • 12.2.2 Chart - BioPharma Market Growth
  • 12.3 Clinical Market
    • 12.3.1 Table - Clinical Market by Country
    • 12.3.2 Chart - Clinical Market Growth
  • 12.4 Other End User Market
    • 12.4.1 Table - Other End User Market by Country
    • 12.4.2 Chart - Other End User Market Growth

13 Appendices

  • 13.1 FDA Cancer Drug Approvals by Year
  • 13.2 Clinical Trials Started 2010 to 2016
  • 13.3 Prevalence of Cancer Treatments